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Information processing in cortical neuronal networks relies on properly balanced excitatory and 23 
inhibitory neurotransmission. A ubiquitous motif for maintaining this balance is the somatostatin 24 
interneuron (SOM-IN) feedback microcircuit. Here, we investigate the modulation of this 25 
microcircuit by presynaptic GABAB receptors (GABABRs) in the rat hippocampus. Whole-cell 26 
recordings from SOM-INs reveal that both excitatory and inhibitory synaptic inputs are strongly 27 
inhibited by GABABRs, while optogenetic activation of the interneurons shows that their 28 
inhibitory output is also strongly suppressed. Electron microscopic analysis of immunogold-29 
labelled freeze-fracture replicas confirms that GABABRs are highly expressed presynaptically at 30 
both input and output synapses of SOM-INs. Activation of GABABRs selectively suppresses the 31 
recruitment of SOM-INs during gamma oscillations induced in vitro. Thus, axonal GABABRs are 32 
positioned to efficiently control the input and output synapses of SOM-INs and can functionally 33 
uncouple them from local network with implications for rhythmogenesis and the balance of 34 







The ability of cortical networks to process information requires a fine spatiotemporal balance of 40 
glutamatergic excitation and GABAergic inhibition. Inhibition in these circuits arises from 41 
GABAergic interneurons (INs), which target either the perisomatic or dendritic regions of 42 
principal cells (PCs) and are embedded in the local network in feedback or feedforward (Booker 43 
and Vida, 2018; Klausberger and Somogyi, 2008). A subpopulation of IN expresses the 44 
neuropeptide somatostatin and innervates the distal apical dendritic tufts of PCs and INs 45 
(Katona et al., 1999; McBain et al. 1994). SOM-INs act as a ubiquitous inhibitory feedback 46 
element in hippocampal and neocortical circuits, due to their preferential excitatory input from 47 
local PCs (Ali and Thomson, 1998; Blasco‐Ibáñez and Freund, 1995; Lacaille et al., 1987; 48 
Müller and Remy, 2014; Shigemoto et al., 1996; Urban-Ciecko et al., 2018; Yuan et al., 2017). 49 
Besides controlling dendritic excitability and synaptic plasticity at the single-cell level, 50 
hippocampal SOM-INs contribute to the co-ordination of population activity, particularly in the 51 
theta frequency range (4-12 Hz) (Gloveli et al., 2005b; Klausberger et al., 2003; Maccaferri and 52 
McBain, 1996), but also at higher frequencies in the beta and lower gamma band (Chen et al., 53 
2017; Hakim et al., 2018). They gate information flow between and within cortical areas (Leão et 54 
al., 2012; Naka et al., 2019) and support learning and memory processes (Lovett-Barron et al., 55 
2014; Abbas et al., 2018; Adler et al., 2019).  56 
 57 
Cortical INs are themselves strongly controlled by inhibitory mechanisms produced through both 58 
ionotropic GABAA receptors (GABAAR) and metabotropic GABABRs (Kulik et al., 2018). SOM-59 
INs in the hippocampal CA1 have been shown to receive a strong GABAAR-mediated synaptic 60 
input from local INs, dominantly those expressing calretinin (CR) and vasoactive intestinal 61 
peptide (VIP) (Tyan et al., 2014). GABAAR-mediated inhibition onto INs has been linked to 62 
disinhibitory network mechanisms (Acsády et al., 1996) and the emergence of coherent 63 
oscillatory network activity (Bartos et al., 2002; Bartos et al., 2007; Traub et al., 1999; White et 64 
al., 2000). In contrast, the contribution of GABABRs to network functions is less well understood 65 
(Booker et al., 2013; Brown et al., 2007; Kohl and Paulsen, 2010) despite the ubiquitous 66 
expression and abundant distribution of GABABRs at both pre- and postsynaptic locations on 67 
PCs and INs alike (Kulik et al., 2006; Kulik et al., 2003). We have recently shown that CA1 68 
SOM-INs express high levels of postsynaptic GABABRs and their activation does not activate 69 
Kir3 channels, rather they inhibit dendritic L-type (Cav1.2) calcium channels to suppress 70 
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synaptic plasticity (Booker et al., 2018). This result raises the question: do presynaptic 71 
GABABRs contribute to short-term, direct inhibition of synaptic transmission at the input and 72 
output synapses of SOM-INs, leading to circuit level disinhibition? In fact, presynaptic GABABR-73 
mediated inhibition would be able to efficiently control IN recruitment and to functionally 74 
uncouple them from the local network (Huh et al., 2016; Urban-Ciecko et al., 2015). 75 
 76 
In this study, we first characterized the surface expression, localization and function of 77 
presynaptic GABABRs at input and output synapses of SOM-INs in CA1 of the rodent 78 
hippocampus by combining in vitro electrophysiology with optogenetics and quantitative 79 
immunoelectron microscopy. We then assessed the impact of GABABR activation on network 80 




Presynaptic GABABRs Strongly Inhibit Glutamatergic and GABAergic Synaptic Inputs 85 
onto SOM-INs 86 
As SOM-INs largely lack postsynaptic GABABR mediated K+-currents (Booker et al., 2018), we 87 
hypothesize that this receptor may confer presynaptic inhibition at synaptic inputs onto SOM-INs 88 
from CA1 PCs. Therefore, we performed whole-cell recordings from the INs combined with 89 
extracellular stimulation of their inputs in the alveus in rat acute hippocampal slices (Figure 1). 90 
We identified SOM-INs during the recordings as neurons having (1) their soma located at the 91 
str. oriens/alveus border, (2) high-frequency, but accommodating discharge pattern and (3) a 92 
large “sag” in response to hyperpolarizing current steps during the recordings (Figure 1A). After 93 
the recordings, immunoreactivity for SOM was confirmed in 63 visualized INs (Figure 1A, 94 
Booker et al., 2018); cells that were negative for SOM were excluded. Most Visualized SOM-INs 95 
in rat slices showed characteristic horizontally-oriented dendrites restricted to the str. 96 
oriens/alveus and 25 cells (39.7%) possessed an axon projecting to the str. lacunosum-97 
moleculare (Figure 1A); consistent with the morphological features of oriens/alveus-lacunosum-98 
moleculare (OLM) INs as described previously (McBain et al., 1994; Katona et al., 1999). 99 
Further 2 INs (3.2%) had bistratified axons in str. radiatum and oriens, 4 (6.4%) had axons 100 
confined to str. oriens only. The remaining INs either had axons cut close to the soma (8 cells, 101 
12.7%) or were not sufficiently filled to allow morphological identification (24 cells, 38.1%). This 102 
division of cell identity is comparable to that we have observed previously (Booker et al., 2018). 103 
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In an additional set of recordings from mouse slices (see below), we identified 15 SOM-INs, of 104 
which 7 were OLM cell (46.7%), 2 were bistratified cell (13.3%), the remainder had a cut axon (1 105 
cell) or not filled sufficiently (5 cells) to be identify morphologically. 106 
 107 
In the presence of GABAAR antagonists (gabazine or bicuculline, both 10 µM), alveus 108 
stimulation produced short-latency EPSCs with an average amplitude of 77.7 ± 16.1 pA (10 109 
cells) and a strong facilitation with a paired-pulse ratio (PPR) of 1.8 ± 0.2 in response to paired-110 
pulses (100 µs, 50 ms interval, Figure 1B), typical of CA1 PC synapses (Lacaille et al., 1987). 111 
Application of baclofen (10 μM) decreased the mean EPSC amplitude by 84% to 12.2 ± 2.2 pA 112 
(t(d.f.19) = 3.96, p = 0.001, Holm-Sidak test), but increased the PPR to 2.8 ± 0.5 (t(d.f.25) = 2.94, p = 113 
0.025, Holm-Sidak test, Figure 1C,D) indicating a reduction in the glutamate release probability 114 
at presynaptic terminals by GABABR activation. Subsequent CGP (5 μM) application to the bath 115 
in a subset of experiments (8 cells) recovered the EPSCs to baseline levels with a mean 116 
amplitude of 89.7 ± 13.7 pA (t(d.f.25) = 0.68, p = 0.502, Holm-Sidak test) and PPR of 1.8 ± 0.2 117 
(t(d.f.19) = 2.8, p = 0.025, Holm-Sidak test, Figure 1C,D). The AMPA receptor (AMPAR) 118 
antagonist NBQX (10 μM), applied at the end of a subset of these experiments (5 cells) reduced 119 
the average EPSC amplitude by 97% to 3.5 ± 1.5 pA (U(d.f. 4) = 0.0, p = 0.0006, Mann-Whitney 120 
test), confirming that responses were mediated by glutamatergic synapses. 121 
 122 
To explore whether the GABABR-mediated suppression of feedback CA1 input to SOM-INs was 123 
species specific, we performed the similar recordings in wild-type mice (5 cells; Figure 1-figure 124 
supplement 1). Under control conditions, stimulation of the alveus resulted in an average 125 
EPSC of 62.1 ± 8.5 pA (Figure 1-figure supplement 1A,B) which following bath application of 126 
a low concentration of baclofen (2 µM) was reduced by 57% to 26.7 ± 4.9 pA (F(d.f.2,4) = 15.9, p = 127 
0.0016, 1-way ANOVA; t = 4.9, p=0.002, Holm-Sidak test; Figure 1-figure supplement 1B,C). 128 
Sebsequent bath application of 5 µM CGP fully reversed the observed inhibition to 101.1% of 129 
control (t = 0.01, p=0.99, Holm-Sidak test). These data confirm that strong presynaptic inhibition 130 




SOM-INs receive strong GABAergic input from a subset of local CR- and VIP-expressing INs 135 
(Acsády et al., 1996; Tyan et al., 2014). We therefore asked whether GABAAR-mediated IPSCs 136 
6 
 
in SOM-INs show a similar sensitivity to GABABR activation. Paired-pulse extracellular 137 
stimulation to the str. oriens proximal to these recorded SOM-INs (9 cells) in the presence of 138 
AMPAR and NMDAR antagonists (10 µM NBQX and 50 µM APV) gave rise to large 139 
monosynaptic IPSCs with an average amplitude of 158.9 ± 34.4 pA and a depressing PPR of 140 
0.82 ± 0.05 (Figure 1D). Activation of GABABRs by bath application of baclofen (10 μM) 141 
reduced the IPSC amplitude by 69% to 49.5 ± 13.2 pA (t(d.f.16) = 5.07, p = 0.0003, Holm-Sidak 142 
test), but had minimal and non-significant effect on the PPR (0.97 ± 0.05; t(d.f.16) = 1.58, p = 143 
0.251, Holm-Sidak test; Figure 1F,G). CGP (5 M) application recovered the IPSC amplitude to 144 
97% of control levels (154.5 ± 27.7 pA, t(d.f.16) = 0.205, p = 0.84, Holm-Sidak test; Figure 1F,G). 145 
Application of bicuculline (10 μM) following CGP recovery inhibited the IPSCs by 94% to 146 
9.9 ± 2.1 pA (U(d.f.9) = 0, p = 0.0006, Mann-Whitney test; Figure 1D), confirming their GABAAR-147 
mediated nature. Thus, our data show that presynaptic GABABRs strongly control the strength 148 
of both excitatory and inhibitory synaptic inputs onto CA1 SOM-INs. 149 
 150 
To examine the strong GABABR-mediated inhibition at single excitatory input synapse onto 151 
SOM-INs, we next performed paired whole-cell recordings between synaptically coupled CA1 152 
PCs and INs (Figure 2). From a total of 42 tested CA1 PC - SOM-IN paired recordings, in 5 153 
pairs (12%) we could observe a unitary synaptic coupling in response to a train of presynaptic 154 
APs (Figure 2A). No IPSCs elicited by SOM-IN were detected in any of the simultaneously 155 





Figure 1. Synaptic Inputs to SOM-INs are Strongly Inhibited by Presynaptic GABABR Activation . 159 
(A) A reconstruction of a SOM-IN showing soma and dendrites (black) and axon (red) with respect to the 160 
layers of the CA1 area. Inset (top left), intrinsic physiological response to current injections (500 ms 161 
duration; -250 pA to 250 pA). Inset (right), immunoreactivity for SOM (green) in the same biocytin-filled 162 
cell (bioc, blue). The arrows indicate SOM immunoreactivity in somata of the biocytin filled (upper) and 163 
non-filled (lower) INs. Scale: 20 µm. (B, upper) EPSCs elicited in a SOM-IN by alveus stimulation in the 164 
presence of 10 µM bicuculline, during control (left), baclofen (10 µM, middle, control traces are overlain in 165 
red) and CGP-55,845 (CGP, 5 µM, right) bath application. (B, lower) time-course plot of the mean EPSC 166 
amplitude in 10 SOM-INs during control, and sequential bath application of baclofen, CGP and NBQX 167 
(10 µM). (C,D) Summary bar graphs of EPSC amplitudes and PPRs under control conditions (Ctrl) and 168 
during baclofen and subsequent CGP application from 9 SOM-INs. E Monosynaptic IPSCs evoked by 169 
stimulation of str. oriens in the presence of NBQX and APV (50 µM, top) and time-course plot of the mean 170 
IPSC amplitude from 9 SOM-INs (bottom) during control, and sequential bath application of baclofen, 171 
CGP and bicuculline (Bic, 10 µM). (F,G) Summary bar graphs of IPSC amplitudes and PPR from 9 SOM-172 
INs. Connected circles correspond to data obtained from a single SOM-IN in the different conditions. 173 
Statistics shown: ns – p > 0.05, * – p < 0.05, ** – p < 0.01, *** - P<0.001; all from repeated measures 174 
ANOVA with Holm-Sidak post-tests. Abbreviations: Ori - str. oriens, Pyr - str. pyramidale, Rad - str. 175 





Figure 2. Unitary EPSCs from PCs onto SOM-INs are Strongly 179 
Inhibited by Presynaptic GABABRs . (A) Reconstruction of a 180 
synaptically coupled CA1 PC (soma/dendrites in blue, axon in 181 
green) and SOM-IN pair (soma/dendrites in black, axon in red). 182 
Inset (bottom right) shows a train of APs (upper trace) evoked 183 
by a depolarizing current applied to the CA1 PC (500 pA, 500 ms) 184 
eliciting a shower of EPSCs in the voltage-clamped SOM-IN 185 
(lower trace). (B) Unitary EPSCs in the SOM-IN (average trace: 186 
black line; individual traces: grey lines) produced by single action 187 
potentials evoked by short depolarizing current pulses (1 ms, 1-188 
2 nA) in the CA1 PC. Time course of the unitary EPSC amplitude 189 
from the same recording under control conditions and during 190 
baclofen (2 µM) and CGP (5 µM) application. (C) Summary bar 191 
chart of mean EPSC amplitude in 5 CA1 PC/SOM-IN pairs during 192 
control conditions (Ctrl), baclofen (Bac) and CGP steady states. 193 
(D) Summary data for EPSC failure rate recorded under the same 194 
conditions. Connected circles correspond to data obtained from a 195 
single PC - SOM-IN pair in the different conditions. Statistics 196 
shown: ns – p > 0.05, * – p < 0.05, ** – p < 0.01, *** - P<0.001; all 197 
from repeated measures ANOVA with Holm-Sidak post-tests. 198 
 199 
Single action potentials in the presynaptic CA1 PC 200 
produced short latency unitary EPSCs with an average 201 
amplitude of 7.1 ± 1.7 pA (range: 2.5 – 12.0 pA; Figure 202 
2B,C) and a failure rate of 61.5 ±7.2% in SOM-INs (Figure 2D). Application of a lower baclofen 203 
concentration (2 μM), reduced the mean EPSC amplitude by 74% to 1.6 ± 0.9 pA (t(d.f. 8) = 3.96, 204 
p = 0.01, Holm-Sidak test; Figure 2B,C), consistent with the strong reduction observed with 205 
extracellular stimulation (U(d.f.13)= 24, p = 0.945, Mann-Whitney test). Under this condition, the 206 
failure rate increased to 84.8 ± 6.3% (t(d.f.8) = 3.3, p = 0.022, Holm-Sidak test; Figure 2D), 207 
indicating that the release probability was significantly reduced. Subsequent Application of 5 μM 208 
CGP recovered both the EPSC amplitude (t(d.f. 8) = 0.18, p = 0.86, Holm-Sidak test) and failure 209 
rate (t(d.f. 8) = 1.35, p = 0.21, Holm-Sidak test, Figure 2C,D) to control levels. These data, thus, 210 
confirm that GABABRs strongly inhibit excitatory synaptic inputs from local PCs onto SOM-INs, 211 
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indicating a pivotal role of this receptor in controlling SOM-IN recruitment in this feedback 212 
inhibitory microcircuit. 213 
 214 
GABABR Subunits are Expressed at Presynaptic Boutons Forming Synapses Onto SOM-215 
INs 216 
To investigate the molecular basis of the strong inhibition at excitatory and inhibitory inputs to 217 
SOM-INs, we next assessed GABABR expression at presynaptic boutons contacting SOM-IN 218 
dendrites in str. oriens/alveus of CA1. We performed high-resolution quantitative SDS-FRL 219 
analysis from perfusion-fixed rat hippocampal sections (Booker et al., 2017; Figure 3-figure 220 
supplement 1). Antibodies used targeted intracellular epitopes of the proteins of interest - 221 
receptors, ion channels, transporters and yellow fluorescent protein (YFP) - and, therefore, 222 
resulted in labeling of the protoplasmic face (P-face) but not of the exoplasmic face (E-face) of 223 
the replicas (Figure 3-figure supplement 1A-C). We first double-labelled replicas for the 224 
constitutive GABAB1 subunit and mGluR1α, which specifically labels CA1 SOM-INs (Baude et 225 
al., 1993). We consistently observed a high surface expression of GABAB1 subunits on 226 
presynaptic terminals contacting horizontal, sparsely spiny mGluR1α-immunolabelled dendrites 227 
in str. oriens/alveus (Figure 3-figure supplement 1A,C) demonstrating the presence of the 228 
receptor at virtually all synapses. To examine the presence of GABABRs at glutamatergic and 229 
GABAergic presynaptic boutons, we performed double immunolabeling for GABAB1 with the 230 
vesicular glutamate transporter 1 (VGluT1), which selectively labels excitatory terminals in the 231 
hippocampus. We observed consistent GABAB1 labeling at both VGluT1-positive and 232 
transporter-negative boutons with an apparently higher density of the receptor subunit in 233 





Figure 3. Localization of the GABAB1 Subunit to Axon Terminals Contacting SOM-IN Dendrites in 237 
str. oriens . (A) Electron micrograph showing the localization of GABAB1 (6 nm particles) to synaptic 238 
membranes, identified by immunoreactivity for CaV2.1 (12 nm), and extrasynaptic membrane of axon 239 
terminals of putative excitatory (b1) and inhibitory (b2, b3) neurons making synapses onto a dendrite 240 
(DenSOM) of a mouse ChR2-YFP-expressing (18 nm) SOM-IN. (B, C) High magnification views of the 241 
boxed areas of the SOM-IN dendrite in (A). Note that there are three other presumed excitatory boutons 242 
(b4-6) contacting dendrite of the IN. Abbreviations: P-face, protoplasmic face; E-face, exoplasmic face; cf, 243 
cross-fractured face. Scale bars: 200 nm. 244 
 245 
To directly assess and quantify the subcellular organization and density of GABABRs on 246 
dendritic and axonal compartments of SOM-INs, we utilized a novel approach by combining 247 
transgenic mouse strategy with the SDS-FRL immunoelectron microscopy. The SOM-Cre 248 
mouse line was crossed with the Ai32(RCL-ChR2(H134R)/EYFP) line leading to selective 249 
expression of the ChR2-YFP fusion protein in every SOM-IN. As ChR2 renders the fusion 250 
11 
 
protein membrane bound, selective labelling of SOM-IN surface membranes in SDS-FRL 251 
replicas can be performed by using an antibody against YFP, thus, allowing for a reliable 252 
identification of the INs in SDS-FRL labelling (Schönherr et al., 2016; Trusel et al., 2019). 253 
Indeed, by co-labeling for YFP and mGluR1, we found that 96% of YFP-positive dendritic 254 
shafts in the str. oriens (27 out of 28 dendrites) also showed immunoreactivity for this marker 255 
glutamate receptor (Figure 3-figure supplement 2), confirming that YFP was reliably 256 
expressed and detected in SOM-INs in replicas from the transgenic mice. Furthermore, the 257 
surface density of immunogold particles for GABAB1 on YFP-positive dendritic membranes in 258 
double-labelled replicas from the transgenic mice was comparable to that previously found in 259 
mGluR1-positive SOM-IN dendrites from rat hippocampal CA1 (54.61 ± 2.52 particles/µm2 on 260 
YFP-positive mouse dendrites, Figure 3-figure supplement 3, and 49.1 ± 4.5 particles/µm2 in 261 
mGluR1-positive rat dendrites; Booker et al. 2018) indicating a convergence between the two 262 
rodent species. In the replicas from transgenic mice, we next performed triple labelling for 263 
GABAB1, YFP and Cav2.1 as a marker for presynaptic active zone (Althof et al., 2015) (Figure 264 
3). In good agreement with the findings from rat, we observed an abundant surface expression 265 
of the receptor subunit on presynaptic terminals in contact with YFP-positive dendritic shafts of 266 
SOM-INs in the str. oriens in the mice (Figure 3A). Immunoparticles for GABAB1 were mainly 267 
confined to and distributed non-homogeneously over the active zones (AZs) of terminals 268 
(Figure 3B,C), which were recognized by their high density of intramembrane particles on the 269 
P-face of the invaginated plasma membrane and a strong immunolabeling for Cav2.1 (Althof et 270 
al., 2015). Furthermore, receptor subunits were occasionally seen along the extrasynaptic 271 
membrane of presynaptic boutons (Figure 3B,C).  272 
 273 
We next asked to what extent GABAB1 surface localization is segregated between excitatory 274 
and inhibitory presynaptic terminals targeting dendritic shafts of SOM-INs. To address this 275 
question, we performed triple-immunolabeling for GABAB1, YFP and either VGluT1 or vesicular 276 
GABA transporter (VGAT), which selectively label boutons of glutamatergic and GABAergic 277 
neurons, respectively (Figure 4). In these replicas, we consistently observed labeling for 278 
GABAB1 in both populations of terminals, but immunoreactivity for the receptor subunit was 279 
significantly higher in VGAT-positive and VGluT1-negative inhibitory terminals (43.00 ± 6,61 280 
particles/µm2, n=36) compared to VGAT-negative and VGluT1-positive excitatory presumed PC 281 
axon terminals (17.36 ± 2.13 particles/µm2, n=60; p < 0.0001, Mann-Whitney test; Figures 4B-282 
D). These data demonstrate that both GABAergic and glutamatergic terminals forming synapses 283 
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onto SOM-INs contain large numbers of GABABRs, consistent with electrophysiological findings 284 
demonstrating a robust presynaptic inhibition at inhibitory and excitatory inputs, however, with a 285 
substantial difference in the surface density between the two bouton populations. 286 
 287 
 288 
Figure 4. GABAB1 Expression on Inhibitory and Excitatory Axon Terminals Forming Synapses 289 
onto SOM-IN Dendrites. (A) Electron micrographs showing immunogold labeling for GABAB1 (6 nm, 290 
arrows) on a VGAT-immunonegative (bVGAT-) and a VGAT-immunopositive (bVGAT+; 12 nm) axon terminal 291 
contacting a ChR2-YFP-immunopositive dendritic shaft (18 nm) of a SOM-IN (DenSOM). (B) Expanded 292 
view of the VGAT-immunonegative terminal identified in A, with GABAB1 labelling highlighted (red 293 
overlay). (C) Expanded view of the VGAT-immunopositive  terminal identified in A, with GABAB1 294 
highlighted. (D) Summary bar graph of GABAB1 labelling density on excitatory (VGAT- and VGluT1+) and 295 
inhibitory (VGAT+ and VGluT1-) axon terminals. Data from individual compartment is shown as open 296 
circles. Density of GABAB1 is significantly higher in inhibitory boutons compared to excitatory terminals 297 
(****p <0.0001, Mann-Whitney test). Abbreviations: E-face, exoplasmic face; P-face, protoplasmic face; 298 




Activation of GABABRs Inhibits GABA Release from SOM-IN Axon Terminals 301 
We next asked, whether the output synapses of SOM-INs onto CA1-PCs are inhibited by 302 
GABAB autoreceptors. Given that in acute slice preparations SOM-INs have a very low 303 
connection probability to CA1-PCs (Ali and Thomson, 1998), we utilized ChR2 activation of 304 
SOM-IN axons in SOM-Cre transgenic mice (Savanthrapadian et al., 2014; Yuan et al., 2017) to 305 
examine the synaptic output of SOM-INs (Figure 5). For this purpose hippocampal slices were 306 
prepared from SOM-Cre transgenic mice injected with rAAVs containing ChR2 and tdTomato 307 
between inverted incompatible tandem loxP sites. This viral strategy allowed spatially restricted 308 
expression of ChR2 to CA1. The expression pattern which was detected by the fluorescence 309 
intensity of tdTomato reporter was highest in str. oriens, primarily localized to somata and 310 
dendrites, and str. lacunosum-moleculare showing a more diffuse axonal labeling (Figure 5A). 311 
At the cellular level this expression was restricted to SOM-INs (Figure 5A, inset, bottom). 312 
 313 
Figure 5. SOM-IN Output Synapses are 314 
Inhibited by GABABRs . (A) Confocal image 315 
stack of a recorded and biocytin-filled CA1 316 
PC (white pseudocolor) in slice from SOM-317 
Cre transgenic mouse transfected with ChR2-318 
tdTomato (tom, red). The slice was 319 
counterstained with DAPI (blue) to reveal 320 
hippocampal layering, including the cell body 321 
layer (Pyr). Inset (right), plot of the 322 
fluorescence intensity in the red channel for 323 
the ChR2-tdTomato fusion protein across 324 
CA1 layers. Inset (bottom), co-localization of 325 
tdTomato (tom, red) with SOM 326 
immunofluorescence (green). Scale bars: 327 
50 µm (main) and 20 µm (inset). (B, upper) 328 
IPSCs recorded in a CA1 PC following photo 329 
stimulation of SOM-IN axons in the CA1. 330 
Individual sweeps (grey) are overlaid with the averaged traces (in black) for control, baclofen (10 µM) and 331 
CGP (5 µM) conditions. (B, lower) Time-course plot of IPSC amplitudes obtained from the CA1 PC 332 
during control and sequential bath application of baclofen and CGP. (C) Summary bar chart of mean 333 
IPSC amplitudes from 6 CA1 PCs in control, baclofen and CGP conditions. (D) Summary bar chart of 334 
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IPSC amplitudes from 7 CA1 PCs with the same pharmacological tests, but in the continuous presence of 335 
SCH-23,390 (SCH, 10 µM) to block Kir3 channels. E Mean IPSC amplitudes normalized to control in the 336 
presence of baclofen (6 cells), SCH and baclofen (7 cells), and CGP alone (4 cells). Connected circles 337 
correspond to data obtained from a single PCs under the different conditions. Statistics shown: ns – 338 
p>0.05, * p<0.05, ** p<0.01 from Holm-Sidak tests.  339 
 340 
Optogenetic activation of SOM-IN axons in the str. lacunosum-moleculare resulted in 341 
temporally-aligned IPSCs in CA1 PCs with an average peak amplitude of 14.0 ± 3.6 pA (6 cells, 342 
Figure 5B,C). Baclofen application markedly reduced the optically-evoked IPSC amplitudes by 343 
61% to 5.3 ± 1.3 pA (t(d.f. 8) = 4.31, p = 0.007, Holm-Sidak test, Figure 5B,C) indicating the 344 
presence of presynaptic GABABRs at SOM-IN output synapses. Subsequent CGP bath-345 
application (4 cells) recovered the IPSC amplitude to 119% of control (15.2 ± 3.4 pA, 346 
t(d.f. 8) = 0.12, p = 0.90, Holm-Sidak test, Figure 5B,C). However, GABABR activation also 347 
produced a strong IWC of 49 ± 15 pA postsynaptically (6 cells, Figure 5-figure supplement 348 
1A,B), plausibly due to Kir3 channel opening in CA1 PC dendrites (Degro et al., 2015). This 349 
postsynaptic conductance may shunt the evoked IPSCs and contribute to their reduced 350 
amplitudes during baclofen application. Therefore, to isolate the contribution of presynaptic 351 
GABABRs, in a set of experiments we pre-applied the Kir3 channel blocker SCH-23,390 (SCH, 352 
10 µM; Kuzhikandathil and Oxford, 2002). Pre-application of SCH reduced the baclofen-induced 353 
IWC in CA1 PCs to 19 ± 3 pA (7 cells, t(d.f. 11) =1, p = 0.002, Mann-Whitney test, Figure 5-figure 354 
supplement 1C). In the presence of SCH, the IPSC elicited by optogenetic activation of SOM-355 
IN axons had an average amplitude of 7.0 ± 1.3 pA (Figure 5D), tending to be smaller than 356 
IPSCs elicited in PCs recorded in the absence of SCH, albeit not significantly so (U(d.f. 11) = 9, p 357 
= 0.10, Mann-Whitney test). Baclofen application under this condition inhibited the IPSC by 70% 358 
to 2.3 ± 0.4 pA (t(d.f. 7) = 4.82, p = 0.002, Holm-Sidak test, Figure 5D). The effect of baclofen was 359 
reversed by consecutive CGP application (Figure 5D). The baclofen-induced presynaptic 360 
inhibition of SOM-INs IPSCs in the presence of SCH was comparable to that of baclofen applied 361 
alone (t(d.f. 14) = 0.2, p = 0.84, Holms-Sidak test, Figure 5E), indicating that the observed 362 
reduction in the IPSC amplitude was not contaminated by a Kir3-mediated postsynaptic 363 
shunting effect in the PCs. These data, thus, confirm that GABABRs are present in the axon-364 
terminals of SOM-INs and strongly inhibit the synaptic output of these INs. Although recent 365 
observations indicate that ChR2 expression can interfere with presynaptic GABABR function (Liu 366 
et al., 2018), the strong inhibition observed in our study argues against such a scenario under 367 




Presynaptic GABABRs are Present at High Density on Axon Terminals of SOM-INs 370 
Our electrophysiological data clearly indicate the presence of functional presynaptic GABABRs 371 
in axon terminals of SOM-INs. Therefore, we next examined the surface density and subcellular 372 
organization of GABAB1 in axon terminals of the INs by quantitative SDS-FRL immunoelectron 373 
microscopy in replica samples from the str. lacunosum-moleculare of CA1 (Figure 6) using the 374 
same ChR2-YFP-based approach as described above. Triple-immunolabeling of freeze-fracture 375 
replicas for YFP, GABAB1 and Cav2.1 unequivocally demonstrated a high number of GABAB1 376 
over the plasma membrane of all analyzed YFP-immunoreactive boutons (Figure 6A-C). There 377 
was no significant difference in the density of immunoparticles for the receptor subunit on YFP-378 
positive terminals (45.57 ± 2.31 particles/µm2, n=66) of SOM-INs and YFP-negative putative PC 379 
boutons (41.56 ± 4.71/µm2, n=41; p=0.099, Mann-Whitney test) (Figure 6D). Furthermore, 380 
detailed analysis revealed that 20% and 37% of the terminals possess high number of synaptic 381 
(Figure 6A) and perisynaptic (Figure 6B) receptors, respectively, whereas 43% of them contain 382 
exclusively extrasynaptic GABAB1 (Figure 6C). These data suggest a substantial heterogeneity 383 





Figure 6. GABAB1 Subunit Expression and Localization on SOM-IN Axon Terminals.  387 
(A-C) Electron micrographs showing GABAB1 (6 nm particles, red overlay) localized to the active zone 388 
(az) (A), identified by immunolabeling for Cav2.1 (12 nm, green overlay), to the perisynaptic membrane 389 
(B) and to the extrasynaptic domain (A-C) of YFP+ (18 nm) boutons (b) of SOM-INs. Note that 390 
extrasynaptic Cav2.1 channels were not highlighted in A and B. Arrowheads indicate docked and 391 
predocked vesicles on cross-fractured face (cf) of a bouton in A. (D) Summary bar chart of the average 392 
GABAB1 density on YFP+ boutons, compared to nearby YFP- boutons. Data from individual compartment 393 
is shown (open circles) with number of analyzed terminals in parenthesis. ns – p > 0.05. Mann-Whitney 394 
test. Scale bars: 200 nm. 395 
 396 
Presynaptic GABABRs Functionally Uncouple SOM-INs from the Local Microcircuit  397 
SOM-INs participate in synchronized hippocampal network oscillations, in particular in theta but 398 
also gamma frequency (30 - 100 Hz) activity (Gloveli et al., 2005b; Hájos et al., 2004; Huh et al., 399 
2016; Maccaferri and McBain, 1996). Given the near complete inhibition of excitatory, as well as 400 
inhibitory synaptic inputs onto SOM-INs by presynaptic GABABRs, we asked whether this 401 




First, we induced slow, theta frequency oscillations in hippocampal slices by bath applying 404 
carbachol (50 μM; Figure 7A). We recorded extracellular theta activity in 8 slices and in 5 of 405 
these slices SOM-INs were recorded simultaneously to the local field potential. The peak power 406 
of the oscillatory activity in the field was 27.5 ± 7.0 μV2 at a frequency of 9.8 ± 1.5 Hz (Figure 407 
7B). During the oscillations, SOM-INs had an average discharge frequency of 13.0 ± 3.2 Hz with 408 
the APs occurring at the rising phase of the theta cycle (Figure 7C), consistent with the 409 
discharge pattern observed in vivo (Forro et al., 2015). Application of 2 μM baclofen resulted in 410 
a strong, 78% reduction in the theta peak power to 8.8 ± 3.3 μV2 (t(d.f.8) = 3.8, p = 0.015, Holm-411 
Sidak test; Figure 7A,B). The reduction in theta power was complemented by a near-complete 412 
loss of SOM-IN discharge (mean frequency of 0.4 ± 0.2 Hz; t(d.f. 8) = 3.3, p = 0.03, Holm-Sidak 413 
test, Figure 7A,D). Both the theta peak power (21.5 ± 5.0 μV2; t(d.f. 8) = 1.22, p = 0.26, Holm-414 
Sidak test; Figure 7B) and the discharge frequency (14.1 ± 4.0 Hz; t(d.f. 8) = 0.12, p = 0.91, Holm-415 
Sidak test; Figure 7D) were fully reversed by subsequent bath application of 5 μM CGP, 416 
confirming that the silencing of SOM-INs was mediated by GABABRs. Recordings from CA1 417 
PCs (4 cells) showed that their peak discharge frequency (control: 3.9 ± 1.5 Hz) was markedly 418 
reduced, but not abolished during baclofen application (1.4 ± 0.9 Hz; t(d.f.3) = 3.7, p = 0.025, 419 
Holm-Sidak test), reflecting that the effect of GABABR activation had a network wide impact. 420 
The discharge of PCs, similar to that of the INs, was fully recovered by CGP application 421 
(4.1 ± 1.4 Hz; t(d.f.3) = 1.21, p = 0.258, Holm-Sidak test) 422 
 423 
SOM-INs are also recruited to gamma oscillations (Tort et al., 2007), therefore, we next tested 424 
the effects of presynaptic GABABR activation on SOM-IN firing during this faster activity pattern. 425 
Kainate puff application (2 mM, 100 ms) to str. radiatum at a distance of ~100 μm from the 426 
recorded SOM-IN, resulted in large amplitude fast gamma oscillations lasting 5-10 seconds in 427 
the local field potential recorded from the str. radiatum (Figure 7E). These oscillations had a 428 
peak power of 52.6 ± 14.3 μV2 at 61.1 ± 4.4 Hz (Figure 7F). During the kainate-induced gamma 429 
oscillations SOM-INs fired at 7.7 ± 2.0 Hz (6 cells, Figure 7H), comparable to that observed 430 
during theta oscillations (U(d.f. 9) = 7, p = 0.16, Mann-Whitney test). Individual APs in SOM-INs 431 
preferentially occurred at the ascending phase of gamma oscillation, on average -15 ± 10° 432 
before the peak of the oscillatory cycle (Figure 7G,I) indicating a high correlation and tight 433 
phase relationship to local network activity, despite their low discharge frequency. Bath 434 
application of 2 μM baclofen reduced the peak power of gamma oscillations by ~45% to 435 
28.7 ± 12.0 μV2 (F(d.f. 2,10) = 5.13, p = 0.029, 1-way ANOVA; Figure 7F) with minimal effect on 436 
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the frequency (65.5 ± 3.8 Hz, t(d.f.10) = 1.1, p = 0.51, Holm-Sidak test). Baclofen application also 437 
produced a near-complete loss of APs in SOM-INs (6 cells) reducing the discharge frequency to 438 
0.7 ± 0.2 Hz (t(d.f.5) = 3.6, p = 0.04, Holm-Sidak test, Figure 7H). In contrast, baclofen application 439 
only marginally affected the discharge frequency of CA1 PCs under the same conditions (3 440 
cells) reducing it from 9.6 ± 2.2 Hz to 7.9 ± 3.9 Hz (t(d.f.2) = 0.7, p = 0.80, Holm-Sidak test). 441 
 442 
Given the near-complete loss of SOM-IN discharge, it was not possible to assess whether 443 
presynaptic GABABR activation led to a breakdown of SOM-IN phase coupling to the 444 
oscillations. Therefore, we applied a depolarizing current to SOM-INs to promote their firing in 445 
the presence of baclofen. When SOM-INs were held near their rheobase current (106 ± 31 pA; 446 
Figure 7I, middle) in the presence of 2 µM baclofen, they fired at low frequency (2.9 ± 0.6 Hz). 447 
Under these conditions, the APs showed no preference to the phase of gamma activity (F(d.f. 448 
18,57) = 1.8, p = 0.048, 2-way repeated-measures ANOVA). The discharge frequency (11.6 449 
± 3.2 Hz, p = 0.22, Holm-Sidak test; Figure 7H) as well as the phase preference (25 ± 22°, 450 
Figure 7I, right) recovered during subsequent application of CGP (5 µM, without bias current). 451 
 452 
To confirm that the strong inhibition of SOM-IN discharge during gamma oscillations was not 453 
species specific, we performed the same experiments in acute hippocampal slices from mice 454 
(Figure 7-figure supplement 1). Puff application of kainate to str. radiatum produced reliable 455 
gamma oscillations with a peak power of 52.8 ± 19.2 µV2 at a frequency of 44.9 ± 9.4 Hz (4 456 
slices, Figure 7-figure supplement 1A,B). Bath application of 2 µM baclofen reduced the peak 457 
power to 36.6 ± 13.2 µV2 (F(d.f. 2,7) = 38.4, p = 0.0002 1-way ANOVA; p = 0.001, Holm-Sidak test; 458 
Figure 7-figure supplement 1B). Simultaneous intracellular recording from SOM-INs during 459 
the kainate-puff-induced gamma oscillation revealed a discharge in the theta range with a mean 460 
frequency of 7.9 ± 0.9 Hz under control conditions. Similar to the observations in rat slices, 461 
application of baclofen also strongly attenuated discharge to 1.6 ± 0.7 Hz in mouse SOM-INs 462 
(t(d.f. 7)=6.0, p=.0.001, Holm-Sidak test; Figure 7-figure supplement 1C). The oscillatory power 463 
as well as the spike rate recovered with subsequent 5 µM CGP bath-application in 2 SOM-INs 464 
tested (Figure 7-figure supplement 1B,C). These results are consistent with a network 465 
uncoupling of SOM-INs by presynaptic GABABR activation in both rats and mice.  466 
 467 
To demonstrate that the reduction in spiking was not due to a global reduction in excitability, as 468 
caused by bath application of baclofen, we performed experiments in which we focally applied 469 
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baclofen (2 mM) via a second puff electrode in close proximity to the SOM-IN somata (Figure 7-470 
figure supplement 2). Under control conditions, the peak power of gamma oscillations induced 471 
by the kainate puff to the str. radiatum was 48.8 ± 11. 2 µV2 at 37.0 ± 2.4 Hz in these 472 
experiments (Figure 7-figure supplement 2A,B). Focal puff application of baclofen to str. 473 
oriens had no significant effect on the peak power of gamma activity in 8 slices tested 474 
(37.6 ± 9.3 µV2; F(d.f. 2,16) = 0.33, p = 0.72; 1-way ANOVA; p = 0.82, Holm-Sidak test; Figure 7-475 
figure supplement 2B). Despite no change in peak gamma power, the focal baclofen 476 
application produced a near complete abolition of SOM-IN discharge from 10.2 ± 3.7 Hz under 477 
control conditions to 0.1 ± 0.1 Hz during the baclofen puff in 6 SOM-INs (F(d.f. 2,13) = 4.7, p = 478 
0.028 1-way ANOVA; p = 0.032, Holm-Sidak test; Figure 7-figure supplement 2C). The 479 
reduction in SOM-IN firing was reversed to 7.8 ± 1.7 Hz by bath application of 5 µM CGP during 480 
the baclofen puff in 4 cells (Compared to control: p = 0.54, Holm-Sidak test) confirming the 481 
GABABR dependence of this effect.  482 
 483 
In summary, GABABR mediated inhibition is very strong at synaptic inputs to SOM-INs and can 484 




Figure 7. Presynaptic GABABR-mediated Inhibition Functionally Uncouples SOM-INs from the 487 
Local Network.  488 
(A) Dual extracellular field (upper) and whole-cell (lower) recordings from a CA1 SOM-IN in longitudinal 489 
acute hippocampal slice during theta frequency oscillations induced by bath application of 50 µM 490 
carbachol. Representative traces are shown in control conditions (left), and during application of baclofen 491 
(2 µM, middle), or subsequent application of CGP (5 µM, right). (B) Spectral analysis of the field 492 
oscillations under control conditions (grayscale), during baclofen (Bac, green) and subsequent CGP 493 
(magenta) application (7 slices). Inset, Bar chart of the average peak power for the three pharmacological 494 
conditions. (C) Spike triggered average of the field potential (grey trace) ±75 ms from the AP in a SOM-IN 495 
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(blue, superimposed; left) illustrating the firing preference at the rising phase of the oscillations. Inset 496 
(right), polar plot of the phase preference of SOM-IN discharge with respect to the oscillatory cycle. (D) 497 
Summary bar chart of the average discharge frequency of SOM-INs (7 cells) during theta frequency 498 
activity in control conditions and in the presence of baclofen or CGP. (E–H) Corresponding data for 499 
gamma activity induced by 2 mM kainate puff application to str. radiatum of CA1 in horizontal 500 
hippocampal slices. (I) Mean discharge probability of SOM-INs plotted as a function of the phase of 501 
gamma under control conditions (left), in the presence of baclofen (middle, with a bias current applied to 502 
hold the membrane potential of the SOM-IN close to firing threshold), and in the presence of CGP (right, 503 
without bias current). Statistics shown: ns – P>0.05, ** - P<0.01, derived from repeated-measures 504 





In the current study we show that excitatory and inhibitory axon terminals converging onto SOM-510 
INs express high levels of GABABRs and activation of the receptors leads to strong inhibition of 511 
transmission at these synapses. The synaptic output of SOM-INs onto CA1 PC dendrites is 512 
similarly inhibited by GABABR activation. We find that the strong presynaptic GABABR inhibition 513 
observed is sufficient to silence SOM-INs during in vitro theta and gamma oscillations. 514 
Combined, these data provide strong evidence that SOM-INs can be silenced and uncoupled 515 
from hippocampal microcircuits by GABABR-mediated presynaptic inhibitionduring co-ordinated 516 
network activity when extracellular GABA levels surge (Scanziani, 2000). 517 
 518 
Presynaptic GABABR Activation Suppresses Synaptic Inputs Onto SOM-IN 519 
The primary excitatory synaptic input to SOM-INs is from CA1 PCs, making these INs a major 520 
feedback inhibitory element in cortical circuits (Ali and Thomson, 1998; Lacaille et al., 1987; 521 
Shigemoto et al., 1996). Previous studies have demonstrated that PC synapses onto SOM-INs 522 
produce small depolarization, with high failure rates, and strong frequency dependent 523 
facilitation, indicative of a low initial release probability synapse (Pala and Petersen, 2015; 524 
Silberberg and Markram, 2007; Urban-Ciecko et al., 2018). This low basal synaptic transmission 525 
onto SOM-INs has been suggested to arise from multiple presynaptic modulatory pathways, 526 
including group II and III mGluRs (Shigemoto et al., 1996; Losonczy et al., 2003) and 5-HT1A 527 
receptors (Böhm et al., 2015), whereas nicotinic acetylcholine receptors have been recently 528 
shown to boost neurotransmission at these input synapses (Urban-Ciecko et al., 2018). Our 529 
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results reveal that GABABRs are also abundant at presynaptic terminals onto SOM-INs, at both 530 
synaptic and extrasynaptic membranes. While we did not observe evidence for tonic 531 
presynaptic GABABR activation under our experimental conditions, agonist activation 532 
consistently produced inhibition of the glutamatergic input onto SOM-INs, sufficient to strongly 533 
inhibit monosynaptic and unitary EPSCs with concomitant changes in failure rate and PPR, 534 
indicative of a presynaptic locus of action. Plausibly, during periods of high network activity, as 535 
observed in vivo, GABA spill-over from local inhibitory synapses may readily activate GABABRs 536 
(Scanziani, 2000; Oláh et al., 2009) in a dynamic, state-dependent manner. However, higher 537 
ambient levels of GABA could also produce a tonic level of GABABR activation, contributing to 538 
the weak glutamatergic transmission from PCs to SOM-IN, through heterosynaptic receptor 539 
activation (Urban-Ciecko et al., 2015). 540 
 541 
Similar to glutamatergic synapses, we found a consistently high level of surface expression of 542 
GABABRs and a strong presynaptic inhibition at GABAergic synapses onto SOM-INs. Previous 543 
studies indicate that VIP/CR-containing INs account for 70% of all inhibitory synapses onto 544 
SOM-INs (Acsády et al., 1996; Tyan et al., 2014). As such, we infer that the output of VIP/CR 545 
INs is strongly controlled by GABAB autoreceptors. While the precise temporal pattern of this 546 
inhibitory synaptic input to SOM-INs is not known, the strong suppression of transmission during 547 
GABABR activation is likely to contribute to the reduced phase relationship and uncoupling of 548 
these INs from the local network. 549 
 550 
GABABR Expression and Function at the Inhibitory Synaptic Output of SOM-IN 551 
The major SOM-IN output is onto the distal apical dendrites of PCs, and also other INs in 552 
hippocampal CA areas (Katona et al., 1999). Their postsynaptic effects are primarily mediated 553 
by GABAAR (Huh et al., 2016; Maccaferri et al., 2000), but slow GABABR effects have also been 554 
observed in hippocampal and neocortical PCs (Huh et al., 2016; Maccaferri et al., 2000; Urban-555 
Ciecko et al., 2015; Nichol et al., 2018), indicating that in addition to neurogliaform cells (Tamas 556 
et al., 2003; Price et al., 2008; Oláh et al., 2009), SOM-INs may contribute to GABA volume 557 
transmission. Indeed, SOM-INs can produce strong GABABR-mediated heterosynaptic inhibition 558 
at excitatory synapses onto cortical PCs in line with a role in volume transmission (Urban-559 
Ciecko et al., 2015). The observed high density of GABABRs in SOM-IN axon terminals and the 560 
strong depression of their inhibitory output during receptor activation in our optogenetic 561 
experiments demonstrate that GABAB autoreceptors dynamically regulate GABA release from 562 
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these synapses. However, about half (57%) of SOM-IN boutons possessed GABABRs localized 563 
within or in direct apposition to the presynaptic active zone, whereas essentially all terminals 564 
contained extrasynaptic GABABR - a subcellular distribution pattern observed at other cortical 565 
synapses (Kulik et al., 2003). This suggests that a functional dichotomy may exist where most 566 
SOM-IN synapses are regulated by ambient GABA levels, with approximately half of synapses 567 
also inhibited by GABAB autoreceptors. The cellular sources of GABA involved in heterosynaptic 568 
inhibition at the output of SOM-INs is likely to be distinct from those at the input synapses, 569 
however their effects could converge to uncouple the INs from the network under specific 570 
conditions. Alternatively, this distribution pattern may demonstrate a high degree of surface 571 
dynamics of presynaptic GABABRs reflecting the activity level of the INs. This observed 572 
heterogeneity of GABABR compartmentalization and its functional impact in SOM-IN outputs 573 
should be the subject of further studies. 574 
 575 
Role of SOM-INs and GABABRs in Network Activity 576 
SOM-INs are well known to participate in oscillatory activity intrinsic to cortical circuits (Gloveli et 577 
al., 2005a; Hájos et al., 2004; Klausberger et al., 2003; Maccaferri and McBain, 1996; Müller 578 
and Remy, 2014; Pangalos et al., 2013; Tort et al., 2007). In good agreement with previous 579 
findings, both in vitro and in vivo (Gloveli et al., 2005b; Huh et al., 2016; Klausberger et al., 580 
2003; Varga et al., 2012), we observed that hippocampal SOM-INs discharge phase-locked to 581 
the field oscillation during both theta and gamma rhythms. These two oscillatory patterns in vitro 582 
were sensitive to low, presynaptic-selective concentrations of baclofen (Dugladze et al., 2013; 583 
Vigot et al., 2006). This result is complementary to previous findings that GABABR antagonists 584 
increase the oscillatory power in these two frequency bands (Johnson et al., 2017; Leung and 585 
Shen, 2007) and plausibly reflects circuit-wide disinhibition of neuronal excitability and 586 
transmission, enhancing phasic modulation of the network by fast inhibition. However, the 587 
sensitivity of the two oscillatory patterns to GABABR activation was differential in our 588 
experiments: while theta rhythm was almost completely abolished, gamma activity persisted 589 
albeit with a reduced power. The high sensitivity of theta activity to baclofen may reflect an 590 
inherent lability of in vitro theta oscillations. Indeed, only few publications have reported reliable 591 
theta oscillations in ex vivo preparations (Fellous and Sejnowski, 2000; Gloveli et al., 2005a; 592 
Goutagny et al., 2009) which might be due to the strong reliance of an intact connection from 593 
the entorhinal cortex or the septum (Buzsáki, 2002). However, given the proposed central role 594 
of SOM-INs in the generation of theta activity (Forro et al., 2015; Gloveli et al., 2005a; Hájos et 595 
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al., 2004; Klausberger et al., 2003; Sekulić and Skinner, 2017), synaptic uncoupling of the INs 596 
by presynaptic GABABRs may also be causally related to the abolished theta activity. In this 597 
context the persistence of gamma oscillations could be explained by their microcircuit 598 
mechanisms involving other IN types, in particular fast-spiking basket cells (Bartos et al., 2002; 599 
Bartos et al., 2007).  600 
 601 
Pharmacological models of gamma do not fully reflect the nuances of in vivo activity, and as 602 
such rarely does gamma exist as a prolonged 5-10 second barrage, but rather occurs co-603 
generated with theta as nested short bursts both in the hippocampus and in the neocortex 604 
(Bragin et al., 1995; Johnson et al., 2017; Strüber et al., 2017). As SOM-INs are recruited to 605 
these oscillations they rhythmically discharge and provide inhibition to the apical dendrites of 606 
PCs. In the CA1, this inhibition gates the entorhinal inputs to PCs (Leão et al., 2012) and has an 607 
essential role in learning and memory processes (Lovett-Barron et al., 2014). Our results show 608 
that presynaptic GABABRs are strategically positioned at both input and output synapses of 609 
SOM-INs in this generic cortical microcircuit motif, and can exert strong suppression on 610 
transmission. As SOM-IN recruitment and their precisely-timed discharge are primarily defined 611 
by their excitatory input from PCs (Huh et al., 2016; Urban-Ciecko et al., 2018) the strong 612 
suppression by GABABRs alone at this synapse, may be sufficient to uncouple and silence 613 
SOM-INs. However, the parallel suppression of GABAergic input synapses will leave the SOM-614 
INs with minimal phasic synaptic control from the active network. Silencing of SOM-IN firing 615 
allows for a breakthrough of multi-sensory inputs from the temporoammonic pathway onto 616 
hippocampal PCs, leading to strengthened inhibition and suppressed plasticity at 617 
intrahippocampal connections (Leão et al., 2012). The differential sensitivity of gamma and 618 
theta oscillations further suggests that the uncoupling of SOM-INs from the network by GABABR 619 
activation may also modify the balance of these activity patterns. GABABR-mediated 620 
suppression of SOM-IN output provides a convergent mechanism for the modulation of this 621 
feedback microcircuit. However, in view of the wide spatial separation of input and output 622 
synapses in str. oriens and str. lacunosum-moleculare, ambient GABA levels, and thus GABABR 623 
activation, likely displays both temporal and pathway specific separation. 624 
 625 
Taken together, the data we present suggest that the activity of SOM-INs, a major feedback 626 
element in cortical circuits, is strongly regulated by presynaptic GABABRs at their input and  627 
output synapses. The suppression of synaptic transmission serves to functionally silence and 628 
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uncouple SOM-INs from ongoing coordinated network activity. These actions of GABABRs can 629 
fine tune inhibition/excitation balance in a compartment specific-manner and thereby tightly 630 




MATERIALS AND METHODS 633 
 634 
Animals 635 
Electrophysiological experiments were performed in acute slices prepared from 17 - 26 day-old 636 
wild-type and transgenic Wistar rats expressing Venus/yellow fluorescence protein (YFP) under 637 
the vesicular GABA transporter (VGAT) promoter (Uematsu et al., 2007) or 25-30 day old wild-638 
type mice (C57/Bl6JCRL). For optogenetic experiments, 10 – 12-week-old SOM-Cre mice 639 
(Jackson Laboratories; Ssttm2.1(cre)Zjh/J; Taniguchi et al. 2011) were bilaterally injected with 640 
rAAVs containing Channelrhodopsin2 (ChR2) and tdTomato (tdTom) coding regions between 641 
inverted incompatible tandem loxP sites into the hippocampal CA1 area (Coordinates from 642 
Bregma: 2 mm, 2 mm; 1.4 mm; 3 µl volume, 3 mins). Optogenetic experiments were performed 643 
2 - 4 weeks following viral injection. Electron microscopy was performed on either 8-week-old 644 
male Wistar rats or 6-week-old male SOM-cre mice crossed with Ai32 (RCL-645 
ChR2(H134R)/EYFP) transgenic mice (The Jackson Laboratory, stock number: 024109, Maine). 646 
Care and handling of the animals prior to and during the experimental procedures followed 647 
European Union and national regulations (German Animal Welfare Act; ASPA, United Kingdom 648 
Home Office) and all experiments were performed in accordance with institutional guidelines 649 
(Charité - Universitätmedizin Berlin; University of Freiburg, Freiburg, Germany), with 650 
permissions from local authorities (LaGeSo, Berlin, T-0215/11 LaGeSo; Freiburg, X14/11H and 651 
35-9185.81/G-19/59). 652 
 653 
Acute slice preparation 654 
Acute hippocampal slices were prepared and recordings performed as previously described 655 
(Booker et al., 2014). Briefly, rodents were decapitated (either directly or following cervical 656 
dislocation) and their brain rapidly dissected and chilled in semi-frozen carbogenated (95% O2 / 657 
5% CO2) sucrose-substituted artificial cerebrospinal fluid (sucrose-ACSF, in mM: 87 NaCl, 658 
2.5 KCl, 25 NaHCO3, 1.25 NaH2PO4, 25 glucose, 75 sucrose, 7 MgCl2, 0.5 CaCl2, 1 Na-659 
Pyruvate, 1 Na-Ascorbate). Transverse hippocampal slices (300 or 400 μm thick) were cut on a 660 
vibratome (VT1200s, Leica, Germany) and stored submerged in sucrose-ACSF warmed to 35°C 661 
for at least 30 min and subsequently at RT. For recording of network oscillations, slices were 662 
stored in a liquid/gas interface chamber, which was perfused with normal ACSF (in mM: 663 
125 NaCl, 2.5 KCl, 25 NaHCO3, 1.25 NaH2PO4, 25 glucose, 1 MgCl2, 2 CaCl2, 1 Na-Pyruvate, 664 
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1 Na-Ascorbate, pH 7.4) at 30 - 32°C from slicing until recording in order to maintain active 665 
oscillatory activity (Hájos et al., 2009). 666 
 667 
Whole-cell patch-clamp recordings 668 
For electrophysiological recordings, slices (300 μm thick) were placed in a submerged recording 669 
chamber, perfused with carbogenated ACSF at 10 - 12 ml/min and maintained at near 670 
physiological temperatures (32 ± 1 °C) using an inline heater (Supertech Instruments, Pécs, 671 
Hungary). Slices were viewed under infrared Köhler illumination by means of an upright 672 
microscope (BX-50 or BX-51, Olympus, Hamburg, Germany or SliceScope, Scientifica, UK) with 673 
a 40x water-immersion objective lens (N.A. 0.8). Whole-cell patch-clamp recordings were 674 
accomplished using either an AxoPatch 200B or Multiclamp 700B amplifier (Molecular Devices, 675 
USA) and recording pipettes pulled from borosilicate glass capillaries (2 mm outer / 1 mm inner 676 
diameter, Hilgenberg, Germany) on a horizontal electrode puller (P-97, Sutter Instruments, CA, 677 
USA). Pipettes were filled with intracellular solution (in mM: 120 K-Gluc, 20 KCl, 2 MgCl2, 678 
10 EGTA, 10 HEPES, 2 Na2-ATP, 0.3 Na2-GTP, 1 Na2-Creatinine, 0.1% biocytin [Invitrogen, 679 
UK], pH 7.3, 290 – 310 mOsm) giving pipette resistances of 3 - 5 MΩ. All voltage-clamp 680 
recordings were performed at a holding potential of -65 mV and all current-clamp recordings 681 
were made from the resting membrane potential (VM). In voltage-clamp mode, series resistance 682 
(Rs) was monitored, but not compensated. All signals were filtered online at 10 kHz using the 683 
built in 2-pole Bessel filter of the amplifiers, and digitized at 20 kHz (CED 1401, Cambridge 684 
Instruments, Cambridge, UK, NI USB-6212 BNC, National Instruments, Berkshire, UK, or 685 
Digidata 1550B, Axon Instruments, USA), using WinWCP (courtesy of John Dempster, 686 
Strathclyde University, Glasgow, UK; http://spider.science.strath.ac.uk/sipbs/software_ses.htm) 687 
or pClamp (Axon Instruments, USA). Data was analyzed offline using the open source Stimfit 688 
software package (Guzman et al., 2014) or MATLAB (Mathworks, USA). 689 
 690 
We selected SOM-INs for recording on the basis of being YFP-positive cells with a soma at the 691 
stratum (str.) oriens/alveus border and with horizontal bipolar morphology. Recordings from CA1 692 
PCs were obtained from YFP-negative neurons in the cell body layer. Cells were 693 
electrophysiologically characterized based on their response to a family of hyper- to 694 
depolarizing current injections (500 ms duration; -250 pA to 250 pA in 50 pA steps). Further 695 
confirmation of SOM-IN identity was based on the presence of a large voltage “sag” in response 696 
to hyperpolarizing current steps and a non-adapting train of action potentials (APs) to 697 
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depolarizing current. Neurons were rejected from further analysis when VM >-50 mV, if APs 698 
failed to overshoot 0 mV, initial Rs exceeded 30 MΩ, or Rs changed by >20% in the course of 699 
the recording. 700 
 701 
Characterization of presynaptic GABABR-mediated inhibition 702 
Pharmacologically isolated postsynaptic currents (EPSC and IPSC) were examined in the 703 
presence of either ionotropic receptor blockers bicuculline or gabazine (10 µM, both) for EPSCs 704 
or NBQX and APV (10 and 50 µM respectively) for IPSCs, which were added to the perfusing 705 
ACSF. To evoke synaptic responses, extracellular stimuli were delivered via a glass monopolar 706 
electrode (patch pipettes filled with 2 M NaCl, pipette resistance = 0.1 MΩ) placed 50-100 µm 707 
distal from the cell body in either the alveus (EPSCs) or str. oriens (IPSCs). PSC’s were elicited 708 
using paired stimulus (2x stimuli at 20 Hz) repeated at 0.1 Hz. Stimulus intensity was titrated to 709 
give a monosynaptic response of approximately 100 pA (range of PSC amplitudes: 19 to 710 
366 pA). Following 5 minutes of stable baseline, the GABABR agonist R-baclofen was applied to 711 
the bath at 10 µM. In a subset of recordings, R-baclofen was added at increasing 712 
concentrations, in 5 min intervals, to assess the dose-response relationship. Following steady-713 
state of baclofen wash-in, we removed baclofen and applied the GABABR antagonist CGP-714 
55,845 (5 µM) to the bath to selectively block GABABRs and confirm receptor specificity. The 715 
amplitude of PSCs was measured over a 10 ms window following the stimulus artifact and mean 716 
data is presented as the average of 12 traces normalized to baseline levels over the 2 minutes 717 
prior to baclofen wash-in. To assess the concentration dependence of postsynaptic R-baclofen 718 
effects, recordings were made from CA1 PCs, rather than from SOM-INs, given the very low-719 
amplitude of postsynaptic GABABR currents observed in these INs (Booker et al., 2018). 720 
 721 
Paired recordings from synaptically coupled CA1 PC-IN pairs 722 
To directly assess presynaptic GABABR-mediated function at CA1 PC to SOM-IN synapses, we 723 
performed paired recordings between CA1 PCs and INs in str. oriens/alveus, as previously 724 
described (Booker et al., 2014). Conditions were the same as those described above, albeit with 725 
a lower intracellular EGTA concentration (0.5 mM) to prevent excessive presynaptic Ca2+ 726 
buffering. Following characterization of intrinsic physiological responses of both pre- and 727 
postsynaptic neurons, trains of 10 APs (elicited by current pulses of 1 - 2 nA, 1 ms, 20 Hz) were 728 
delivered to the PC while recording the IN in voltage-clamp at -65 mV. A unitary synaptic 729 
connection was confirmed as a short latency (<4 ms) EPSCs following the presynaptic APs 730 
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detected in averages of 10 traces. If synaptic connectivity was not observed in the IN, the 731 
recording was abandoned, an outside-out patch formed, and a neighboring CA1 PC recorded. 732 
Once a synaptic connection was found, we recorded >50 traces with unitary EPSCs from the 733 
interneurons elicited by APs evoked in the PCs by brief current pulses (1 - 2 nA, 1 ms) every 5 734 
seconds, then applied 2 μM R-baclofen to the bath for 5 minutes, followed by application of 735 
CGP-55,845 (5 µM), without baclofen. The EPSC amplitude was measured from the preceding 736 
baseline as an average over a 0.4 ms window corresponding to the peak region of the synaptic 737 
responses within 10 ms from the start of the AP. Mean unitary EPSCs are shown and measured 738 
from at least 30 traces. 739 
 740 
Optogenetic activation of SOM-INs 741 
Whole-cell recordings were obtained from CA1 PCs in acute slices (300 μm thick) held at -742 
70 mV in acute slices from mice expressing ChR2 and tdTom specifically in SOM-INs. IPSCs 743 
were evoked by pulses of blue light (473 nm; 2 ms; CoolLED system, UK) centered at the 744 
border of str. radiatum and lacunosum-moleculare repeated at 5 sec intervals. Basal synaptic 745 
transmission was measured and the effect of R-baclofen (10 µM) was analyzed after 5 min of 746 
bath application. In a subset of experiments (4 out of 6), CGP 55845 (5 µM), without baclofen, 747 
was subsequently bath applied and the prior effect of baclofen was fully reversed. In a subset of 748 
recordings, 10 µM SCH-23,390 was preapplied to the bath, after which baclofen and CGP were 749 
then co-applied. Data was obtained from averages of 30 - 50 traces except for the figure 750 
showing the time course of drug effects. 751 
 752 
Generation of network oscillations and field potential recordings 753 
To preserve a larger intact local network, thicker, 400 µm acute hippocampal slices were 754 
prepared (as above) in either the transverse (gamma oscillations) or longitudinal plane (theta 755 
oscillations) (Gloveli et al., 2005a), then stored in a liquid/gas interface chamber. For theta 756 
oscillations, slices were moved from the interface chamber, into a submerged chamber perfused 757 
with ACSF containing 50 µM carbachol at a rate of 10-12 ml/minute. An extracellular recording 758 
electrode made of a patch pipette filled with ACSF was carefully placed in proximal str. radiatum 759 
and the field response recorded. For gamma oscillations slices were transferred to the 760 
submerged recording chamber and a pressure application (“puff”) pipette containing 2 mM 761 
kainate was placed in the distal str. radiatum. Puffs of kainate (10 psi, 20 ms, repeated at 1 762 
minute intervals) were applied to the slice, which invariably resulted in gamma oscillations in the 763 
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field. Once a stable oscillation was confirmed a SOM-IN was recorded from str. oriens and a 764 
minimum of 5 minutes of theta or 5 kainate puffs were collected following recovery of the 765 
oscillation to the previous state. Given the EC50 of R-baclofen being ~1 µM at presynaptic 766 
GABABRs, we applied 2 µM R-baclofen to the bath and following wash in (2 mins) a further 5 767 
minutes of oscillation data were collected. In a subset of recordings, to facilitate AP discharge, a 768 
depolarizing bias current 10 pA below rheobase was applied to the recorded neuron. In a further 769 
subset of recordings a second puff pipette filled with 2 mM baclofen dissolved in 150 mM NaCl 770 
was placed in str. oriens proximal to the recorded IN (<100 µm). First 3 kainate puffs alone were 771 
collects, then 3 puffs where baclofen puff preceded the kainate puff by 100 ms. In some 772 
recordings CGP (5 µM) was applied following R-baclofen to confirm the receptor specificity.  773 
Prior to analysis, all field recordings were band-pass filtered using a Butterworth-filter at 4 - 774 
20 Hz (Theta) or 30 - 200 Hz (Gamma). Peak oscillatory power was measured using fast-775 
Fourier transform (FFT)-based spectral analysis (Spike2 software, CED, Cambridge, UK). Peak 776 
frequency and power were measured across 5 minutes of theta activity following carbachol 777 
wash in or during the initial 10 seconds of gamma activity evoked by the kainate puff. Spike 778 
triggered averages were produced using a custom MATLAB script, over either a 150 ms (Theta) 779 
or 25 ms window (Gamma) (code available on GitHub: https://github.com/imrevida/eLife-780 
Booker-2020-MatlabCode). The relative phase of each AP was determined according to the 781 
Hilbert transform and plotted with respect to the full cycle of each oscillation. Mean AP 782 
frequency was measured as the number of spikes observed over the respective recording 783 
window.  784 
 785 
Visualization, imaging and reconstruction of the recorded neurons 786 
Immunocytochemistry was performed to identify recorded neurons (Booker et al., 2014). 787 
Following experiments, slices were fixed in 4% paraformaldehyde diluted in 0.1 M PB overnight 788 
(O/N) at 4ºC. Slices were rinsed in PB, then phosphate buffered saline (PBS; 0.025 M PB and 789 
0.9% NaCl) and blocked with 10% normal goat serum (NGS) with 0.3 - 0.5% TritonX-100 and 790 
0.05% NaN3 diluted in PBS for 1 hour at RT. Slices were then incubated for 48 - 72 hours in a 791 
PBS solution containing 5% NGS, 0.3 - 0.5% TritonX-100 and 0.05% NaN3 and primary 792 
antibodies against SOM (rabbit polyclonal, 1:2000, Peninsula Laboratories, USA), at 4ºC. Slices 793 
were subsequently rinsed extensively in PBS for an hour and then incubated with fluorescently 794 
conjugated secondary antibodies raised against rabbit (Goat-anti rabbit AlexaFluor 405, 488 or 795 
546; 1:500, Invitrogen, Dunfermline, UK) as well as fluorescently conjugated streptavidin 796 
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(AlexaFluor 647; 1:500, Invitrogen) in a PBS solution containing 3% NGS, 0.1% TritonX-100 797 
and 0.05% NaN3 O/N at 4ºC. Slices were rinsed in PBS, then PB, and mounted on glass slides 798 
with a polymerizing mounting medium (Fluoromount-G, Southern Biotech, AL, USA) and cover-799 
slipped. Filled neurons were imaged with a laser scanning confocal microscope (FluoView 1000, 800 
Olympus) under a 20x (N.A 0.75) objective and z-axis stacks of images (2048x2048 pixels, at 801 
1 μm axial steps) collected to allow identification of somatodendritic and axonal arborizations. 802 
To assess immunoreactivity of the recorded cells the somata and proximal dendrites of neurons 803 
were imaged with a silicon-immersion 60x (N.A. 1.3) objective lens. To confirm immunolabeling 804 
either single confocal images or stacks of 5-10 images at 1 µm axial steps were taken over the 805 
somata. Selected, representative cells were reconstructed off-line from 20x magnification image 806 
stacks digitally stitched using semi-automatic analysis software (Simple Neurite Tracer plug-in 807 
for the FIJI software package, http://fiji.sc) (Longair et al., 2011).  808 
 809 
Sodium dodecyl sulfate-digested freeze-fracture replica immunolabeling (SDS-FRL) 810 
To determine the distribution pattern and density of GABABRs on presynaptic boutons 811 
contacting SOM-INs and axon terminals of the INs, the GABAB1 subunit was detected with SDS-812 
FRL as previously described (Booker et al., 2018). Male mice (6-week-old, n=3) in which SOM-813 
INs selectively expressed ChR2-YFP fusion protein were derived from crossing SOM-Cre and 814 
Ai32 transgenic mice. These mice and male Wistar rats (8-week-old, n=2) were sedated with 815 
Isoflurane and then terminally anesthetized with pentobarbital (80 mg/kg for mice and 50 mg/kg 816 
for rats, intraperitoneally). Animals were then transcardially perfused with 0.9% NaCl for 1 min 817 
followed by a fixative containing 1% paraformaldehyde and 15% saturated picric acid in 0.1 M 818 
PB (pH 7.4) for 12 min. Hippocampal slices (130 µm) were cut on a vibratome (VT 1000, Leica, 819 
Vienna, Austria) and cryoprotected with 30% glycerol in 0.1 M PB O/N at 4°C . Blocks 820 
containing all layers of the CA1 area were trimmed from the slices and frozen under high-821 
pressure (HPM 100, Leica). The frozen samples were fractured at -140°C and the fractured 822 
facets were coated with carbon (5 nm), platinum-carbon (2 nm) and an additional layer of 823 
carbon (18 nm) in a freeze-fracture replica machines (ACE 900, Leica or BAF 060, BAL-TEC, 824 
Lichtenstein). Replicas were digested at 60°C in a solution containing 2.5% SDS and 20% 825 
sucrose diluted in 15 mM Tris buffer (TB, pH 8.3) for 48 hrs followed by 37°C for 18 hrs, washed 826 
in washing buffer comprising 0.05% bovine serum albumin (BSA, Roth, Germany) and 0.1% 827 
Tween 20 in 50 mM Tris-buffered saline (TBS) and then blocked in a solution containing 5% 828 
BSA and 0.1% Tween 20 in TBS for 1 h at RT. Afterwards, replicas were incubated at 15°C for 829 
32 
 
2 days in the following mixtures of primary antibodies in a solution containing 1% BSA and 0.1% 830 
Tween 20 made up in TBS: (i) GABAB1 (B17, rabbit, 10 µg/ml; Kulik et al., 2002 or A25, rabbit, 5 831 
µg/ml; Engle et al., 2006), green fluorescence protein (GFP-1010, chicken, 0.4 µg/ml, Aves 832 
Labs, Oregon) and Cav2.1 (Guinea pig, 4 µg/ml, Frontier Institute, Hokkaido, Japan; Althof et al., 833 
2015) or (ii) GABAB1, GFP and vesicular glutamate transporter 1 (VGluT1, goat, 0.5 µg/ml, 834 
Frontier Institute, Hokkaido; Kusch et al., 2018) or (iii) GABAB1, GFP and vesicular GABA 835 
transporter (VGAT, Guinea pig, 4.5 µg/ml, Frontier Institute, Hokkaido; Althof et al., 2015) or (iv) 836 
GABAB1, GFP, VGluT1 and metabotropic glutamate receptor 1-subunit (mGluR1, Guinea pig, 837 
0.4 µg/ml, Frontier Institute, Hokkaido; Booker et al., 2018). Replicas were washed in washing 838 
buffer then reacted with 6 nm, 12 nm and 18 nm gold particle-conjugated secondary antibodies 839 
(1:30, Jackson ImmunoResearch Europe, Cambridgeshire) or with the aforementioned 840 
antibodies together with 3 nm gold particle- conjugated secondary antibody (1:800, Nanopartz, 841 
Colorado) O/N at 15°C. Finally, replicas were washed in TBS then distilled water and mounted 842 
on Formvar-coated 100-mesh grids. 843 
 844 
Electron microscopy 845 
Replicas were analyzed with an electron microscope (Zeiss Leo 912 omega, Carl Zeiss, 846 
Oberkochen, Germany). All antibodies target intracellular epitopes of proteins, therefore, 847 
immunoreactivity can be observed on the protoplasmic face (P-face) of the plasma membrane. 848 
Boutons contacting YFP-positive dendritic shafts of INs in str. oriens-alveus and YFP-positive 849 
axon terminals of INs in str. lacunosum-moleculare were sampled. Densely spiny CA1 PC 850 
dendrites in str. radiatum, YFP-positive dendritic shafts of SOM-INs in str. oriens-alveus, and 851 
YFP-negative boutons of putative PCs in str. oriens were used as a control for GABAB1 labeling. 852 
 853 
Chemicals and Pharmacology 854 
All chemicals were obtained from either Sigma Aldrich (Munich, Germany) or Carl Roth 855 
(Karlsruhe, Germany). Biocytin was obtained from Life Technologies (Dunfermline, UK). 856 
Pharmacological agents were obtained from Abcam Biochemicals (Cambridge, UK) or Tocris 857 
Bioscience (Bristol, UK). Drugs were stored as 1000-fold concentrated stocks at -80ºC until 858 
used. Working solutions were prepared fresh on the day in normal ACSF at final concentrations 859 
given in the text. 860 
 861 
Statistical Analysis 862 
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Statistical analysis was performed with Graphpad Prism (GraphPad Software, CAUSA). 863 
Analysis of unpaired data was performed with Mann-Whitney U tests. Group data was 864 
compared with one-way ANOVA tests, combined with Holm-Sidak post-tests. Paired group data 865 
was analyzed with one-way repeated measures ANOVA. Data is shown as mean ± SEM 866 
throughout. Statistical significance was assumed if p<0.05. 867 
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SUPPLEMENTARY MATERIAL 1115 
 1116 
Figure 1-figure supplement 1. GABABR mediated inhibition of EPSCs in SOM-INs from mouse 1117 
hippocampus. (A) Representative EPSCs evoked in the presence of 10 µM bicuculline under 1118 
control conditions, and following sequential baclofen (2 µM) and CGP (5 µM) bath application. 1119 
(B) Summary bar chart of EPSC amplitudes in 5 mouse SOM-INs under the same 1120 
pharmacological epochs as in A. Data from individual cells is superimposed as open circles and 1121 
connected with solid lines. Note the strong and consistent inhibition of EPSC amplitude with 1122 
baclofen application. (C) Normalized EPSC amplitudes in the presence of baclofen and CGP 1123 
illustrate the strong inhibition by presynaptic GABABRs. Statistics shown: ns – P>0.05, ** - 1124 






Figure 3-figure supplement 1. Subcellular distribution of the GABAB1 subunit in boutons contacting 1129 
dendritic shafts of oriens-alveus INs in rat hippocampus as revealed by the SDS-FRL method. (A) Low-1130 
power electron micrograph showing an mGluR1a-immunoreactive dendritic shaft (15 nm immunogold 1131 
particles on the protoplasmic face /P-face/ of the plasma membrane) of a putative SOM-expressing IN 1132 
(DenSOM; inset in B) which is targeted by boutons (b1, b2; inset in C) immunolabelled for GABAB1 (10 1133 
nm). (B,C) High resolution electron micrographs of the boxed P-face (B) and E-face areas (C) of 1134 
the SOM-IN dendrite in A. (D, E) Double immunolabeling for vGluT1 (12 nm) and GABAB1 (6 nm) 1135 
revealed that majorityof vGluT1+ excitatory (D, bVGluT1+) as well as vGluT1- putative inhibitory (E, 1136 
bvGluT1-) terminals onto SOM dendrites showed immunoreactivity for GABAB1 (highlighted in red) with 1137 
higher density in GABAergic boutons. Abbreviations: SYE, Postsynaptic density on the E-face of the 1138 





Figure 3-figure supplement 2. Colocalization of genetically encoded ChR2-YFP with mGluR1α 1142 
on putative SOM-IN dendrites. (A) A representative overview image of str. oriens in a SOM-1143 
ChR2-YFP mouse, which is densely labelled for YFP (18 nm immunogold). A region of interest 1144 
on the P-face is indicated by solid lines. (B) The region of interest indicated in A is expanded at 1145 
high magnification to show colocalization of YFP (18  nm immunogold), with mGluR1α (3 nm, 1146 





Figure 3-figure supplement 3. High GABAB1 subunit surface density on YFP-positive dendritic 1150 
shafts located in str. oriens from SOM-ChR2-YFP mice as revealed by the SDS-FRL method. 1151 
(A) Electron micrograph showing a SOM-ChR2-YFP-immunoreactive dendritic shaft (DenSOM), 1152 
which is immunolabelled for YFP (18 nm immunogold particles) and GABAB1 (6 nm). (B) 1153 
Summary bar chart demonstrating that the density of GABAB1 is significantly higher on YFP+ 1154 
dendritic shafts of SOM-INs compared to PC dendrites (****p=0.0001, Mann-Whitney test). Data 1155 
from individual compartment is shown (open circles) with number of analyzed dendrites in 1156 







  1162 
 1163 
Figure 5-figure supplement 1. Whole-cell baclofen-mediated currents in optogenetic 1164 
experiments from CA1 PCs. (A) Summary bar chart of holding currents in voltage-clamped CA1 1165 
PCs (held at -65 mV) recorded for optogenetic stimulation experiments in control conditions, in 1166 
10 µM baclofen and in 5 µM CGP. (B) Subtraction of control baseline allowed measurement of 1167 
the whole-cell current induced by baclofen and CGP. Note the large baclofen induced GABABR-1168 
mediated current and the absence of a current in CGP, suggesting the lack of tonic GABABR 1169 
activation. (C) Summary bar chart of baclofen-induced currents in the absence and presence of 1170 
10 µM SCH-23,390, a Kir3 channel blocker. Note the large reduction in baclofen induced whole-1171 
cell current in the presence of SCH. Statistics shown: ns – P>0.05, * - P<0.01, derived from 1172 







Figure 7-figure supplement 1. SOM-IN spiking is abolished by GABABR activation in the 1178 
hippocampus of mice. (A) Representative traces during 2 mM kainate puff application to the str. 1179 
radiatum, showing the extracellular field oscillations (upper traces) and the discharge of a 1180 
whole-cell recorded SOM-IN (lower traces) in control conditions (top) and during bath 1181 
application of either 2 µM baclofen (middle) or 5 µM CGP (bottom). (B) Average power spectra 1182 
measured from extracellular field recordings during control conditions, baclofen or CGP bath 1183 
application. (C) Summary bar chart of the discharge frequency of SOM-INs measured over the 1184 
10 second period following kainate puff application for control, baclofen, and CGP conditions. 1185 
Data from individual cells is superimposed as connected open circles; numbers of recorded 1186 
cells are indicated below the bars. Statistics shown: ** - P<0.01, derived from repeated-1187 






Figure 7-figure supplement 2. Abolished SOM-IN spiking is due to GABABRs activation in str. 1192 
oriens. (A) Representative trace during 2 mM kainate puff application to the str. radiatum, 1193 
showing the extracellular field oscillations (upper traces) and the discharge of a whole-cell 1194 
recorded SOM-IN (lower traces) in control conditions (top) and during puff application of 2 mM 1195 
baclofen to proximal str. oriens in the absence (middle) or presence of 5 µM bath-applied CGP 1196 
(bottom). (B) Average power spectra measured from extracellular field recordings during control 1197 
conditions and following baclofen puff ± CGP bath application. (C) Summary bar chart of the 1198 
discharge frequency of SOM-INs measured over the 10 second period following combined 1199 
baclofen and kainate puff for control, baclofen puff alone, and baclofen puff with the bath 1200 
applied CGP. Data from individual cells is superimposed as connected open circles; numbers of 1201 
cells are indicated below the bars. Statistics shown: ns- P>0.05 ** - P<0.01, derived from 1202 
repeated-measures ANOVA with Holm-Sidak tests. 1203 
